West Pharmaceutical Servs Sees Q3 Adj EPS $2.14-$2.24 vs $2.12 Est; Sees Sales $820.000M-$835.000M vs $815.707M Est
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. WST | 0.00 |
West Pharmaceutical Servs (NYSE:
WST) is looking for Q3 Adj EPS of $2.14-$2.24 vs $2.12 analyst estimate. sees sales of $820.000 million-$835.000 million vs $815.707 million analyst estimate.
